Assignee
LONGEVERON INC
US·3 granted patents·8 pending applications·0 citations·filing 2017–2025
Top patents by PatentIndex Score
11 records- 0175US2026027158A1Methods of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral ImmunityLONGEVERON INC·Filed 2025·Application pending·0 cites
- 0268US2026009787A1Mmp-14 potency assay for mesenchymal stem cellsLONGEVERON INC·Filed 2025·Application pending·0 cites
- 0364US2024252627A1Mesenchymal stem cells as vaccine adjuvants and methods for using the sameLONGEVERON INC·Filed 2024·Application pending·0 cites
- 0462US2026014205A1Mmp-14 or timp potency assay for mesenchymal stem cellsLONGEVERON INC·Filed 2025·Application pending·0 cites
- 0553US12465620B2Method of treating aging frailty in subjects with inflammaging using human mesenchymal stem cellsLONGEVERON INC·Filed 2017·Granted Nov 11, 2025·0 cites·8 claims
- 0652US2023310509A1Treatment of Alzheimer's Disease with Allogeneic Mesenchymal Stem CellsLONGEVERON INC·Filed 2021·Application pending·0 cites
- 0750US11975068B2Mesenchymal stem cells as vaccine adjuvants and methods for using the sameLONGEVERON INC·Filed 2017·Granted May 7, 2024·0 cites·22 claims
- 0850US2024350551A1Treatment of aging frailty comprising administering bone marrow derived mesenchymal stem cellsLONGEVERON INC·Filed 2022·Application pending·0 cites
- 0950US2024350549A1Use of Mesenchymal Stem Cells in Treatment of Juvenile Hypoplastic Left Heart SyndromeLONGEVERON INC·Filed 2022·Application pending·0 cites
- 1041US12496316B2Treatment of sexual dysfunction and improvement in sexual quality of lifeLONGEVERON INC·Filed 2018·Granted Dec 16, 2025·0 cites·13 claims
- 1139US2023221303A1Potency assayLONGEVERON INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →